Unveiling Pulmonaria rubra Schott: Phytochemical Characterisation and Evaluation of Its Neuroprotective Potential
International Journal of Molecular Sciences · 08.07.2026 · 27 (14) · 6122
DOI: 10.3390/ijms27146122 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.07.2026. Verfasst von Ivan Stambolov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav st., 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Neuroprotective Agents, Plant Extracts, Phytochemicals. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pulmonaria rubra (Boraginaceae) is a widely distributed plant in Bulgaria, yet its phytochemical profile and therapeutic potential have remained unexplored. P. rubra methanol extract (PRE) was evaluated through phytochemical profiling and in vitro neuroprotective and antioxidant assays. Rat brain synaptosomes, mitochondria and microsomes were treated with PRE alone, and in combination with 6-hydroxydopamine and tert-butyl hydroperoxide as toxic agents. The extract exhibited concentration-dependent protective effects in all subcellular models. Additionally, it was tested on hMAOA/B and different isoforms of CYP450 enzymes, but it did not show any activity in the tested conditions. In the UHPLC-HRESIMS analysis, 26 secondary metabolites were identified, mainly hydroxycinnamic acids and caffeoyl oligomers, flavonoids, a lignan (globoidnan A), and the terpenoid glycoside roseoside. Seven compounds were identified via UHPLC-UV method using reference compounds: rosmarinic acid, rutin, quercetin-3-O-glucoside, astragalin, apigenin-7-O-glucoside, apigenin-7-O-glucuronide and alcesefoliside, with the latter two being reported for the first time in genus Pulmonaria. The quantity of rosmarinic acid in PRE was 4.35%, distinguishing the compound as the main bioactive molecule in the species. Characterized by its high content of rosmarinic acid, P. rubra represents a highly viable candidate for subsequent development into standardized phytopharmaceuticals targeting oxidative stress-related neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav st., 1000 Sofia, Bulgaria.
- Laboratory of Drug Metabolism and Drug Toxicity, Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav st., 1000 Sofia, Bulgaria.
ORCID-Profile: Ivan Stambolov, Aleksandar Shkondrov, Ilina Krasteva
Zitieren
APA
Stambolov, I., Shkondrov, A., Vusheva, L., Kondeva-Burdina, M., & Krasteva, I. (2026). Unveiling Pulmonaria rubra Schott: Phytochemical Characterisation and Evaluation of Its Neuroprotective Potential. International Journal of Molecular Sciences, 27(14), 6122. https://doi.org/10.3390/ijms27146122
Vancouver
Stambolov I, Shkondrov A, Vusheva L, Kondeva-Burdina M, Krasteva I. Unveiling Pulmonaria rubra Schott: Phytochemical Characterisation and Evaluation of Its Neuroprotective Potential. International Journal of Molecular Sciences. 2026;27(14):6122. doi:10.3390/ijms27146122
BibTeX
@article{Stambolov2026,
author = {Stambolov, Ivan and Shkondrov, Aleksandar and Vusheva, Lyubomira and Kondeva-Burdina, Magdalena and Krasteva, Ilina},
title = {Unveiling Pulmonaria rubra Schott: Phytochemical Characterisation and Evaluation of Its Neuroprotective Potential},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6122},
doi = {10.3390/ijms27146122}
}
EUVIMED